Potentiation of barbital sodium hypnosis as a screening method for central nervous system depressants.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D002490:Central Nervous System / Q000187:drug effects; D005260:Female; D006591:Hexobarbital / Q000378:metabolism*; D006991:Hypnosis, Anesthetic; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D051379:Mice; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000928:Antidepressive Agents; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D006591:Hexobarbital